Variable prolongation of cardiac allograft survival following intraportal administration of donor antigens.
Kise
Y
Y
Hepato-biliary Surgery and Liver Transplant Center, Paul Brousse Hospital, Villejuif, France.
Farges
O
O
Buffello
D
D
Mansour
I
I
Bismuth
H
H
D000818:Animals; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000008:administration & dosage*; D016027:Heart Transplantation / Q000276:immunology*; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive; D007275:Injections, Intravenous; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D011169:Portal Vein; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
D006680:HLA Antigens